MDGL
NASDAQ · Biotechnology
Madrigal Pharmaceuticals Inc
$432.96
+0.17 (+0.04%)
Performance
1D
+0.04%
1W
+9.25%
1M
-7.32%
3M
-19.25%
6M
-19.81%
1Y
-12.69%
YTD
-27.10%
Open$428.94
Previous Close$432.79
Day High$443.30
Day Low$424.02
52W High$615.00
52W Low$353.54
Volume—
Avg Volume653.8K
Market Cap9.26B
P/E Ratio—
EPS$-5.96
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$484.73
Below
SMA 200
$497.36
Below
RSI (14)
36
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
26 analysts
Price Target
-72.3% upside
Current
$432.96
$432.96
Target
$119.83
$119.83
$78.20
$119.83 avg
$127.79
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 989.84M | 3.52B | 3.21B |
| Net Income | -297,740,286 | -1,086,916,353 | -1,008,552,409 |
| Profit Margin | -30.1% | -30.9% | -31.4% |
| EBITDA | -311,255,505 | -994,214,061 | -913,486,769 |
| Free Cash Flow | — | -874,407,524 | -958,278,915 |
| Rev Growth | — | +9.6% | -7.9% |
| Debt/Equity | 0.56 | 0.46 | 0.46 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.16 | +0.29% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $463.66 | -0.34% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.91 | +0.35% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $550.07 | -0.15% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $911.56 | -0.91% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $151.28 | -3.40% | 7.7 | 20.98B |